Abstract
Atherogenic dyslipidemia in type 2 diabetes mellitus is a significant modifiable factor for cardiovascular disease (CVD), contributing to a high risk of morbidity and mortality. Poor glycemic control in diabetic patients is considered a secondary cause of dyslipidemia, with data from earlier studies indicating that it is a predictor of dyslipidemia, with higher total cholesterol (TC), trigerylcerides (TG), low density lipoprotein (LDL), and decreased high density lipoprotein (HDL). Dyslipidemia is a modifiable risk factor for CVD, thus understanding its impact is critical.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
